Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
Journal of Clinical Psychopharmacology
|
May 20, 2024
Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia
Christoph U Correll, Leslie Citrome, Carlos Singer, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 4, 2013
An accelerometry-based study of lower and upper limb tremor in Parkinson's disease
Blake K Scanlon, Bonnie E Levin, Daniel A Nation, et al.
Journal of the Neurological Sciences
|
April 6, 2011
Two McLeod patients with novel mutations in XK
Patrycja M Dubielecka, Nelson Hwynn, Cenk Sengun, et al.
Parkinsonism & Related Disorders
|
March 3, 2019
Tandem gait abnormality in Parkinson disease: Prevalence and implication as a predictor of fall risk
Jason Margolesky, Sagari Bette, Danielle S Shpiner, et al.
Annals of the American Thoracic Society
|
February 24, 2017
Insomnia, Sleep Quality, and Quality of Life in Mild to Moderate Parkinson's Disease
Shirin Shafazand, Douglas M Wallace, Kristopher L Arheart, et al.
Frontiers in Genetics
|
August 6, 2019
Motivations for Participation in Parkinson Disease Genetic Research Among Hispanics versus Non-Hispanics
Karen Nuytemans, Clara P Manrique, Aaron Uhlenberg, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme
|
December 7, 2018
Hemodynamic responses to an exercise stress test in Parkinson's disease patients without orthostatic hypotension
Kirk B Roberson, Joseph F Signorile, Carlos Singer, et al.
CNS Drugs
|
March 14, 2018
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease
Lawrence W Elmer, Jorge L Juncos, Carlos Singer, et al.
CNS Drugs
|
April 12, 2018
Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease
Lawrence W Elmer, Jorge L Juncos, Carlos Singer, et al.
Neurology. Clinical Practice
|
June 5, 2023
Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT
Stuart H Isaacson, Mark Goldstein, Rajesh Pahwa, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
Journal of Clinical Psychopharmacology
|
May 20, 2024
Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia
Christoph U Correll, Leslie Citrome, Carlos Singer, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 4, 2013
An accelerometry-based study of lower and upper limb tremor in Parkinson's disease
Blake K Scanlon, Bonnie E Levin, Daniel A Nation, et al.
Journal of the Neurological Sciences
|
April 6, 2011
Two McLeod patients with novel mutations in XK
Patrycja M Dubielecka, Nelson Hwynn, Cenk Sengun, et al.
Parkinsonism & Related Disorders
|
March 3, 2019
Tandem gait abnormality in Parkinson disease: Prevalence and implication as a predictor of fall risk
Jason Margolesky, Sagari Bette, Danielle S Shpiner, et al.
Annals of the American Thoracic Society
|
February 24, 2017
Insomnia, Sleep Quality, and Quality of Life in Mild to Moderate Parkinson's Disease
Shirin Shafazand, Douglas M Wallace, Kristopher L Arheart, et al.
Frontiers in Genetics
|
August 6, 2019
Motivations for Participation in Parkinson Disease Genetic Research Among Hispanics versus Non-Hispanics
Karen Nuytemans, Clara P Manrique, Aaron Uhlenberg, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme
|
December 7, 2018
Hemodynamic responses to an exercise stress test in Parkinson's disease patients without orthostatic hypotension
Kirk B Roberson, Joseph F Signorile, Carlos Singer, et al.
CNS Drugs
|
March 14, 2018
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease
Lawrence W Elmer, Jorge L Juncos, Carlos Singer, et al.
CNS Drugs
|
April 12, 2018
Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease
Lawrence W Elmer, Jorge L Juncos, Carlos Singer, et al.
Neurology. Clinical Practice
|
June 5, 2023
Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT
Stuart H Isaacson, Mark Goldstein, Rajesh Pahwa, et al.
Page
of 14